Tag Archives: Novellus Systems

Lam Research Profit Dips 75% – LRCX, AMAT, NVLS, KLAC, INTC, QCOM, STI

Posted on April 19, 2012 by Thomas Vedder

Lam Research Corp. on Wednesday announced a profit of $45.6 million, or 38 cents per share for the quarter closed March 25, against a profit of $182.2 million, or $1.45 per share, for the year-ago period.

Revenue came in at …

Posted in Latest Headlines, Technology | Tagged AMAT, Applied Materials, INTC, Intel, KLA-Tencor, KLAC, Lam Research, LRCX, NASDAQ:AMAT, NASDAQ:INTC, NASDAQ:KLAC, NASDAQ:LRCX, NASDAQ:NVLS, NASDAQ:QCOM, Novellus Systems, NVLS, NYSE:STI, QCOM, Qualcomm, STI, SunTrust Banks | Comments Off

What’s up Zoll Medical, SonoSite and Novellus Systems?

Posted on December 15, 2011 by Cameron White

In this report: Zoll Medical (NASDAQ:ZOLL), SonoSite (NASDAQ:SONO) and Novellus Systems (NASDAQ:NVLS).

Zoll Medical (NASDAQ:ZOLL) is trading over 28 percent higher today after the company announced that the Centers for Medicare and Medicaid Services Durable Medical Equipment Medical Administrative Contractors …

Posted in Latest Headlines, Reports | Tagged acquire, agreed, Buy, cash, company, deal, dealZoll Medical, defibrillators, fujufolm holdings, Lam Research, Medicaid, Medicare, NASDAQ, NASDAQ:NVLS, NASDAQ:SONO, NASDAQ:ZOLL, Novellus Systems, NVLS, outstanding, shares, SONO, SonoSite, tender offer, trading, ultrasound, ZOLL | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

Tag Archives: Novellus Systems

Lam Research Profit Dips 75% – LRCX, AMAT, NVLS, KLAC, INTC, QCOM, STI

What’s up Zoll Medical, SonoSite and Novellus Systems?

Follow us

Most Popular Posts

blogs